2019 Hookworm Infections (Ancylostomiasis) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 51 pages | ID: 2886E1CCB01EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Hookworm Infections (Ancylostomiasis) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hookworm Infections (Ancylostomiasis). It presents in-depth analysis of Hookworm Infections (Ancylostomiasis) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Hookworm Infections (Ancylostomiasis).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Hookworm Infections (Ancylostomiasis) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Hookworm Infections (Ancylostomiasis)

The research work is prepared through extensive and continuous research on Hookworm Infections (Ancylostomiasis) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Hookworm Infections (Ancylostomiasis) patients are identified
• The report includes panorama of Hookworm Infections (Ancylostomiasis) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Hookworm Infections (Ancylostomiasis) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Hookworm Infections (Ancylostomiasis) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Hookworm Infections (Ancylostomiasis) Clinical Trials by Region
  2.2.2 Average Enrollment of Hookworm Infections (Ancylostomiasis) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Hookworm Infections (Ancylostomiasis) Treatment, 2019

3. REGION WISE HOOKWORM INFECTIONS (ANCYLOSTOMIASIS) CLINICAL TRIALS

3.1 Asia Pacific Hookworm Infections (Ancylostomiasis) Clinical Trials by Country
3.2 Europe Hookworm Infections (Ancylostomiasis) Clinical Trials by Country
3.3 North America Hookworm Infections (Ancylostomiasis) Clinical Trials by Country
3.4 Middle East and Africa Hookworm Infections (Ancylostomiasis) Clinical Trials by Country
3.5 South and Central America Hookworm Infections (Ancylostomiasis) Clinical Trials by Country

4. HOOKWORM INFECTIONS (ANCYLOSTOMIASIS) CLINICAL TRIAL TRENDS

4.1 Start Year wise Hookworm Infections (Ancylostomiasis) Clinical Trials
4.2 Phase wise Hookworm Infections (Ancylostomiasis) Clinical Trials
4.3 Trial Status wise Hookworm Infections (Ancylostomiasis) Clinical Trials
4.4 Trial Type wise Hookworm Infections (Ancylostomiasis) Clinical Trials

5. HOOKWORM INFECTIONS (ANCYLOSTOMIASIS) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Hookworm Infections (Ancylostomiasis) Trials by Year
5.2 Average Enrollment in Hookworm Infections (Ancylostomiasis) Trials by Phase
5.3 Average Enrollment in Hookworm Infections (Ancylostomiasis) Trials by Status
5.4 Average Enrollment in Hookworm Infections (Ancylostomiasis) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN HOOKWORM INFECTIONS (ANCYLOSTOMIASIS) CLINICAL TRIALS

6.1 Hookworm Infections (Ancylostomiasis) Trials by Sponsor Type
6.2 Hookworm Infections (Ancylostomiasis) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Hookworm Infections (Ancylostomiasis) Trials- Phase
7.2 Hookworm Infections (Ancylostomiasis) Trials- Phase
7.3 Hookworm Infections (Ancylostomiasis) Trials- Phase
7.4 Hookworm Infections (Ancylostomiasis) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Hookworm Infections (Ancylostomiasis) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Hookworm Infections (Ancylostomiasis) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Hookworm Infections (Ancylostomiasis) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Hookworm Infections (Ancylostomiasis) Clinical Trials and Enrolment
Figure 7: North America – Country wise Hookworm Infections (Ancylostomiasis) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Hookworm Infections (Ancylostomiasis) Clinical Trials and Enrolment
Figure 9: Hookworm Infections (Ancylostomiasis) Clinical Trials by Phase
Figure 10: Hookworm Infections (Ancylostomiasis) Clinical Trials by Trial Status
Figure 11: Hookworm Infections (Ancylostomiasis) Clinical Trials by Type
Figure 12: Hookworm Infections (Ancylostomiasis) Clinical Trials by Sponsor Type
Figure 13: Hookworm Infections (Ancylostomiasis) Clinical Trials by Leading Sponsors
Figure 14: Hookworm Infections (Ancylostomiasis) Average Enrollment by Phase
Figure 15: Hookworm Infections (Ancylostomiasis) Average Enrollment by Trial Status
Figure 16: Hookworm Infections (Ancylostomiasis) Average Enrollment by Type
Figure 17: Hookworm Infections (Ancylostomiasis)- Average Enrolment by Type of Sponsors
Figure 18: Hookworm Infections (Ancylostomiasis)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Hookworm Infections (Ancylostomiasis) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Hookworm Infections (Ancylostomiasis) Clinical Trials and Enrolment
Table 5: Europe – Country wise Hookworm Infections (Ancylostomiasis) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Hookworm Infections (Ancylostomiasis) Clinical Trials and Enrolment
Table 7: North America – Country wise Hookworm Infections (Ancylostomiasis) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Hookworm Infections (Ancylostomiasis) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Hookworm Infections (Ancylostomiasis) Average Enrollment by Phase
Table 15: Hookworm Infections (Ancylostomiasis) Average Enrollment by Trial Status
Table 16: Hookworm Infections (Ancylostomiasis) Average Enrollment by Type
Table 17: Hookworm Infections (Ancylostomiasis)- Average Enrolment by Type of Sponsors
Table 18: Hookworm Infections (Ancylostomiasis)- Enrolment by Leading Sponsors